|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/33 | |
| A61P 25/16 | |||
| A61P 25/08 | |||
| A61P 17/00 | |||
| A61K 49/00 | |||
| A61P 25/06 | |||
| A61K 38/00 | |||
| A61K 8/99 | |||
| A61K 8/64 | |||
| A61K 38/48 | |||
| A61Q 19/08 | |||
| A61K 39/08 |
| (11) | Number of the document | 3242884 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15701379.8 |
| Date of filing the European patent application | 2015-01-09 | |
| (97) | Date of publication of the European application | 2017-11-15 |
| (45) | Date of publication and mention of the grant of the patent | 2021-02-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2015/050043 |
| Date | 2015-01-09 |
| (87) | Number | WO 2016/110662 |
| Date | 2016-07-14 |
| (72) |
ANDERSON, Dina Brady, GB
HACKETT, Gavin Stephen, GB
LIU, Sai Man, GB
|
| (73) |
Ipsen Bioinnovation Limited,
102 Park Drive Milton Park, Abingdon, Oxfordshire OX14 4RY,
GB
|
| (54) | CATIONIC NEUROTOXINS |
| CATIONIC NEUROTOXINS |